Monday, March 26, 2018

Compounding facilities face new FDA regs

Compounding facilities face new FDA regs

ModernMedicine-5 hours ago
Due to problems with compounded medications—including the 2012 fungal meningitis outbreak that led to 64 deaths—FDA is releasing a draft guidance that will determine which bulk drug substances outsourcing facilities can use to compound drugs. “…Compounding from bulk drug substances generally presents greater ...
Post a Comment